Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice.
The manipulation of vascular endothelial growth factor (VEGF)-receptors (VEGFRs) in diabetic nephropathy is as controversial as issue as ever. It is known to be VEGF-A and VEGFR2 that regulate most of the cellular actions of VEGF in experimental diabetic nephropathy. On the other hand, such factors...
Enregistré dans:
Auteurs principaux: | Keun Suk Yang, Ji Hee Lim, Tae Woo Kim, Min Young Kim, Yaeni Kim, Sungjin Chung, Seok Joon Shin, Beom Soon Choi, Hyung Wook Kim, Yong-Soo Kim, Yoon Sik Chang, Hye Won Kim, Cheol Whee Park |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b2b761aa88bb4163a34a1ead5bbd8f2d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Astragalus–Saffron–Rhubarb Mixture Delays the Progress of Diabetic Nephropathy in db/db Mice
par: Zhou XC, et autres
Publié: (2021) -
Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice.
par: Min Hi Park, et autres
Publié: (2013) -
Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice
par: Fu W, et autres
Publié: (2020) -
Renoprotective Effect of Formononetin by Suppressing Smad3 Expression in Db/Db Mice
par: Lv J, et autres
Publié: (2020) -
Valsartan alleviates the blood–brain barrier dysfunction in db/db diabetic mice
par: Longxue Cai, et autres
Publié: (2021)